Performance Review
Despite a year marked by financial challenges, including a regional banking crisis, MassMutual experienced solid underlying earnings, reporting $39 billion in total sales in 2023,See footnote 6 reaching a milestone of more than $1 trillion of life insurance protection in force. Our broad product portfolio, diversified, long-term investment strategy, and a multi-channel distribution approach underpin our company’s track record of success. And the breadth of our product offering provides enormous opportunity for us to help even more people build financial security for themselves and their families. The stability of our business is borne out by our financial strength ratings,See footnote 1 including: A++ Superior by A.M. Best Company, AA+ Very Strong by Fitch Ratings, Aa3 High Quality by Moody’s Investors Service, and AA+ Very Strong by Standard & Poor’s.
- $1.0T Insurance in Force
- $335.3B Total Life Company Assets
- $9.1B Benefits Payout
- $34.5B Total Adjusted Capital
- Nearly $2.2B A Record High Estimated
Dividend Payout for 2024See footnote 2
U.S. Insurance and Annuity Sales (in Millions)
MassMutual sales growth supported by solid life sales as well as record annuity contributions, given our 2021 acquisition of MassMutual Ascend, our expanded distribution, and strong demand given the higher rate environment.
U.S. Whole Life Sales (in Millions)
MassMutual remains an industry leader in whole life sales, with a No. 2 position as of year-end 2023.
Annuity Sales (in Millions)
Annuity sales grew to a new record high, primarily driven by stronger fixed income annuity sales across our distribution channels.
Institutional Sales (in Millions)
In 2023, pension risk transfer and funding agreement-backed notes witnessed solid sales results. We also maintained our strong market rankings across all the institutional markets.
Institutional sales include bank-owned life insurance, corporate-owned life insurance, pension risk transfer, stable value, and funding agreements.
Worksite Sales (in Millions)
Worksite sales growth was primarily driven by stronger whole life sales.
Summary of Financial Position (Consolidated statutory basis, in $ Millions)
As of December 31, 2023: | 2023 | 2022 |
---|---|---|
Short-term investments and cash | 11,941 | 5,737 |
Bonds | 147,300 | 140,394 |
Other invested assets | 103,953 | 105,826 |
Total invested assets | 263,193 | 251,958 |
Other assets | 13,134 | 10,085 |
Separate account assets | 58,997 | 59,537 |
Total assets | 335,324 | 321,579 |
Policyowners’ reserves and other | 191,015 | 175,935 |
Policyowners’ dividends | 2,150 | 1,927 |
Other liabilities | 48,353 | 50,594 |
Asset valuation reserve | 6,071 | 5,774 |
Separate account liabilities | 58,859 | 59,407 |
Total liabilities | 306,447 | 293,638 |
Surplus | 28,877 | 27,941 |
Total liabilities and surplus | 335,324 | 321,579 |
- Total invested assets growth 4.5%
- Increase in total adjusted capital 1.8%
- Increase in surplus 3.3%
Policyowners’ DividendsSee footnote 7 (in Millions)
Our 2023 policyowners’ dividends exceeded $2.1 billion, a new record, affirming our commitment to operate for the benefit of our eligible participating policyowners.
Total Adjusted CapitalSee footnote 3 (in Billions)
Total adjusted capital grew to a record $34.5 billion, continuing to underscore our enduring financial strength.
Total Life Company Assets (in Billions)
Total life company assets grew by more than 4% year-over-year in 2023, to an all-time high, as we continued to conservatively grow our portfolio.